However, many of them have serious concerns about the long-term use of these drugs
ALA: Alpha-Linolenic Acid,GPX4: Glutathione Peroxidase 4, GSH: glutathione, CISD2: CDGSH, Iron Sulfur Domain 2, SLC7A11: Solute Carrier Family 7 Member 11, IGF2BP3: Insulin-Like Growth Factor 2 mRNA, Binding Protein 3, RM: Recurrent miscarriage, EMT: Epithelial-Mesenchymal Transition, HIF1: Hypoxia-Inducible Factor 1 Alpha, lnc-HZ06: Long Non-coding RNA HZ06, NCOA4: Nuclear Receptor Coactivator 4, lncRNA: Long Non-coding RNA, ROS: reactive oxygen species, TP53: Tumor Protein 53, EZH2: Enhancer of Zeste Homolog 2, TIMP1: Tissue inhibitor matrix metalloproteinase 1, SLC3A2: Solute Carrier Family 3 Member 2, GABARAPL2: Gamma-aminobutyric acid receptor-associated protein-like 2
Some peptides are administered for a defined treatment course, while others are continued long-term for ongoing wellness optimization
Another long-acting exenatide, Bydureon, is administrated once weekly
Tesofensine gained attention in obesity research due to clinical findings showing reduced food intake and meaningful body weight reductions in controlled trials
